In the present paper, we investigate the effect of PRIMA-1Met alone or in combination with SAS in cells from CLL patients and CLL cell lines carrying a wt or a mutant p53 protein. The gene discussed is TP53; the disease is B-cell chronic lymphocytic leukemia.